ArticleBioinformation2024
Assessment of crestal bone loss surrounding dental implants using CBCT in different tissue biotypes.
Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marginal bone loss (MBL) is a crucial marker of implant health. Hence this study was done to assess the amount of height of crestal bone lost surrounding dental implants positioned in different tissue types. Twenty six patients with single edentulous areas were divided into two groups at random with 13 samples in each group .Groups A and B comprise implants placed in thick tissue biotypes and thin tissue biotypes, respectively. Cone beam computed tomography (CBCT) was done in both groups at baseline and after implant placement to evaluate the loss of crestal bone surrounding the distal and mesial sides of the implants. Before occlusal loading, at the moment of cementation, a follow-up CBCT was taken. During the time of cementation, both groups experienced a discernible loss of crestal bone on the mesial and distal sides of the implants; however, group B shows a larger loss of crestal bone than group A. Compared to Group A (thick tissue biotype), Group B (thin tissue biotype) had a greater mean crestal bone loss. During the peri-implant healing period, crestal bone alterations are less common in thick biotypes than thin biotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.